Although lack of antidepressant response of two SSRIs evaluated in this study suggest the activation of KOR in treatment resistant depression, further investigation with selective norepinephrine reuptake inhibitors and other serotonerigc antidepressants are warranted to comprehend the underlying molecular pathways completely. This evidence concerns the gene OPRK1 and depressive symptom measurement.